Indications and uses
Symptomatic treatment of molluscum contagiosum
Symptomatic treatment of molluscum contagiosum
Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until skin improves. Molluscum will diminish over 2 to 6 week period. Store at room temperature.
Thuja Occidentalis
The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States
Polypi and Naevi Symptom Relief
Symptomatic treatment of molluscum contagiosum
For external use only.
Virally based infections are contagious. This product will not stop the spread of Molluscum or other viruses.
Do not use - in the eyes - over large areas of the body - if you are allergic to any ingredient in this product.
Ask a doctor before use if pregnant or nursing.
Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days.
If swallowed, call poison control or seek medical help.
Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until skin improves. Molluscum will diminish over 2 to 6 week period. Store at room temperature.
cera alba (organic beeswax), juniperus virginiana (cedarwood) oil, silver oxide, magnesium oxide, peppermint oil, simmondsia chinensis (jojoba) seed oil, zinc oxide
terrasil MAX
Maximum Strength
Molluscum Treatment
Fast - Painless - All-Natural
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24909-145-14 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d9d6-cd31-e053-dbdaa90ab51a | Drug Facts |
| 24909-145-44 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d9d6-cd31-e053-dbdaa90ab51a | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24909-145-14 | Terrasil Molluscum TreatmentMaximum Strength | 14 g in 1 JAR | OINTMENT | 14 | 1 | |
| 24909-145-44 | Terrasil Molluscum TreatmentMaximum Strength | 44 g in 1 JAR | OINTMENT | 44 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| JUNIPERUS VIRGINIANA OIL | INACTIVE INGREDIENT | PAD4FN7P2G | 1 | |
| MAGNESIUM OXIDE | INACTIVE INGREDIENT | 3A3U0GI71G | 1 | |
| PEPPERMINT OIL | INACTIVE INGREDIENT | AV092KU4JH | 1 | |
| SILVER OXIDE | INACTIVE INGREDIENT | 897WUN6G6T | 1 | |
| WHITE WAX | INACTIVE INGREDIENT | 7G1J5DA97F | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24909-145 | 24909-145-14, 24909-145-44 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
| JOJOBA OIL | 724GKU717M | IACT |
| JUNIPERUS VIRGINIANA OIL | PAD4FN7P2G | IACT |
| MAGNESIUM OXIDE | 3A3U0GI71G | IACT |
| PEPPERMINT OIL | AV092KU4JH | IACT |
| SILVER OXIDE | 897WUN6G6T | IACT |
| WHITE WAX | 7G1J5DA97F | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, EXTENDED RELEASE / ORAL | 75 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | POWDER, DENTIFRICE / DENTAL | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SHAMPOO / TOPICAL | 0.2 %w/w | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / BUCCAL | 526 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, DELAYED RELEASE / ORAL | 368 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | LOZENGE / ORAL | 12 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / SUBLINGUAL | 15 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | SUPPOSITORY / RECTAL | 265 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | FILM / BUCCAL | 12 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | POWDER / SUBLINGUAL | 1 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SPRAY, METERED / SUBLINGUAL | 1 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, DELAYED RELEASE / ORAL | 0.08 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / TOPICAL | 500 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, COATED / ORAL | 3 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM, AUGMENTED / TOPICAL | 10 %w/w | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, DELAYED RELEASE / ORAL | 78 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | PASTE, DENTIFRICE / DENTAL | 49.3 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / VAGINAL | 40 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, EXTENDED RELEASE / ORAL | 14 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | AEROSOL, FOAM / TOPICAL | 2 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SUSPENSION / ORAL | 100 mg/1ml | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / ORAL | 63 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET / SUBLINGUAL | 0.15 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | CONCENTRATE / ORAL | 0.05 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SOLUTION / ORAL | 53 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE / ORAL | 79 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET / ORAL | 5 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | CAPSULE / ORAL | 60 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | LOTION / TOPICAL | 1 %w/w | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, EXTENDED RELEASE / ORAL | 25.74 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SOLUTION / DENTAL | 0.04 %v/v | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE / ORAL | 20 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | GUM, CHEWING / BUCCAL | 173 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT / TOPICAL | 2100 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT, AUGMENTED / TOPICAL | 429 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, FILM COATED / ORAL | 80 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE, EXTENDED RELEASE / ORAL | 71 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SYRUP / ORAL | 120 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | FILM, SOLUBLE / BUCCAL | 3 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | ELIXIR / ORAL | 0.04 mg/1ml | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / ORAL | 526 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET / ORAL | 28 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 20d7e5e9-8d88-483d-a7dd-b67e7f184459 | cfa83c79-2aa2-4d01-b3c8-1da094e71af2 | 2012-10-15 | Warnings | 20d7e5e9-8d88-483d-a7dd-b67e7f184459 cfa83c79-2aa2-4d01-b3c8-1da094e71af2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.